Market Overview
The PET scanners market comprises clinical PET/CT systems, standalone PET imaging devices, and preclinical PET scanners used in pharmaceutical research and small-animal imaging. With nearly 20 PET radiopharmaceuticals currently carrying market authorization across the US, Europe, and Australia, the market demonstrates significant clinical adoption and regulatory acceptance. The sector operates within the broader diagnostic imaging services market, which encompasses PET, MRI, and CT technologies.
- •Market valued at $148.8 billion in 2025 with 6.83% annual growth trajectory
- •Approximately 20 PET radiopharmaceuticals authorized for clinical use across major markets
- •Includes clinical whole-body systems and preclinical small-animal imaging platforms
Growth Drivers
The market is experiencing unprecedented expansion fueled by a 75% increase in FDA-approved PET tracer options entering clinical practice between 2020 and 2023. This proliferation of tracers has significantly broadened diagnostic capabilities, enabling more precise imaging for oncology, neurology, and cardiology applications. Additionally, technological evolution from conventional PET to advanced platforms, including time-of-flight and total-body PET systems, is driving replacement cycles and new installations.
- •75% surge in FDA-approved PET tracers between 2020-2023
- •Nearly 20 radiopharmaceuticals with market authorization across US, Europe, and Australia
- •Technological upgrades to time-of-flight and total-body PET platforms stimulating demand
Segmentation and Regional Analysis
The market segments into clinical PET/CT systems, standalone PET scanners, and multimodal imaging platforms, with growing demand in both healthcare institutions and research facilities. Regional distribution shows strong penetration in North America and Europe, where regulatory frameworks support advanced imaging adoption, while emerging markets in Asia-Pacific are expanding diagnostic capacity. NHS England and similar agencies worldwide track actual scan utilization metrics to guide capacity planning through 2030.
- •Clinical systems dominate alongside growing preclinical and research segments
- •North America and Europe lead in adoption, with Asia-Pacific showing expansion
- •Healthcare agencies monitor actual scan volumes to project future capacity requirements
Trends and Outlook
What are the recent trends and outlook?
AI integration and regulatory standardization are transforming the PET scanner market, with artificial intelligence enhancing image reconstruction, quantification accuracy, and diagnostic workflow efficiency. Sustainable manufacturing practices and circular economy principles are becoming priorities, with industry roadmaps addressing hardware lifecycle management and environmental footprint reduction through 2030. Supply chain considerations, including semiconductor and rare earth material availability, continue to influence manufacturing strategies and procurement planning.
- •AI integration improving image quality and quantitative imaging standardization
- •Sustainability initiatives targeting manufacturing footprint and hardware lifecycle management
- •Supply chain factors including semiconductor and specialized materials affecting production
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.